Estimation of risk and interaction of single nucleotide polymorphisms at angiotensinogen locus causing susceptibility to essential hypertension: A case control study

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 13, Issue 4, 2012, Pages 461-471

  Charita, Bh ^a   Padma, G ^a   Sushma, P ^a   Deepak, P ^b   Padma, T ^a  

^a OSMANIA UNIVERSITY   (India)

^b GANDHI MEDICAL COLLEGE   (India)

Author keywords

angiotensinogen (AGT); epistatic interaction; Essential hypertension (EHT); haplotype association; linkage disequilibrium (LD); multifactor dimensionality reduction (MDR); single nucleotide polymorphism (SNP); statistical package for social sciences (SPSS)

Indexed keywords

ANGIOTENSINOGEN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET; DNA FLANKING REGION; EATING HABIT; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYLOGENETIC TREE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSINOGEN; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIFACTOR DIMENSIONALITY REDUCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84870025718     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312444650     Document Type: Article

References (77)

1. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell. 1992 ; 71: 169-180
2. Caulfield M, Lavender P, Farrall M, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994 ; 330: 1629-1633
3. Caulfield M, Lavender P, Newell-Price J, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest. 1995 ; 96: 687-692
4. Atwood LD, Kammerer CM, Samollow PB, et al. Linkage of essential hypertension to the angiotensinogen locus in Mexican Americans. Hypertension. 1997 ; 30: 326
5. Niu T, Xu X, Rogus J, et al. Angiotensinogen gene and hypertension in Chinese. J Clin Invest. 1998 ; 101: 188-194
6. Brand E, Chatelain N, Keavney B, et al. Evaluation of the angiotensinogen locus in human essential hypertension-A European study. Hypertension. 1998 ; 31: 725-729
7. Isa MN, Boyd E, Morrison N, et al. Assignment of the human angiotensinogen gene to chromosome 1q42-q43 by nonisotopic in situ hybridization. Genomics. 1990 ; 8: 598-600
8. Gaillard-Sanchez I, Mattei MG, Clauser E, et al. Assignment by in situ hybridization of the angiotensinogen gene to chromosome band 1q4, the same region as the human renin gene. Hum Genet. 1990 ; 84: 341-343
9. Jeunemaitre X, Inoue I, Williams C, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet. 1997 ; 60: 1448-1460
10. Rodríguez-Pérez JC, Rodríguez-Esparragón F, Hernández-Perera O, et al. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: The procagene study. J Am Coll Cardiol. 2001 ; 37: 1536-1542
11. Pereira AC, Mota GFA, Cunha RS, et al. Angiotensinogen 235T allele "dosage" is associated with blood pressure phenotypes. Hypertension. 2003 ; 41: 25
12. Li NF, Zhou L, Wu WD, et al. The relationship between the variants in 5′ upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 ; 21: 23-28
13. Van den Born BJ, Van Montfrans, G A, Uitterlinden AG, et al. The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients. J Hypertens. 2007 ; 25: 2227-2233
14. Pereira TV, Nunes ACF, Rudnicki M, et al. Meta-analysis of the association of 4 angiotensinogen polymorphisms with essential hypertension. A role beyond M235T?. Hypertension. 2008 ; 51: 778
15. Fang YJ, Deng HB, Thomas GN, et al. Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese. J Hypertens. 2010 ; 28: 1203-1209
16. Ji LD, Zhang LN, Shen P, et al. Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population: A meta-analysis. J Hypertens. 2010 ; 28: 419-428
17. Rotimi C, Morrison L, Cooper R, et al. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension. 1994 ; 24: 591-594
18. Fornage M, Turner ST, Sing CF, et al. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: A population-based case-control study from Rochester, Minnesota. Hum Genet. 1995 ; 96: 295-300
19. Niu T, Chen C, Yang J, et al. Blood pressure and the T174M and M235T polymorphisms of the angiotensinogen gene. Ann Epidemiol. 1999 ; 9: 245-253
20. Kato N, Sugiyama T, Morita H, et al. Angiotensinogen gene and essential hypertension in the Japanese: Extensive association study and meta-analysis on six reported studies. J Hypertens. 1999 ; 17: 757-763
21. Kato N, Sugiyama T, Morita H, et al. Comprehensive analysis of the renin-angiotensin gene polymorphisms with relation to hypertension in the Japanese. J Hypertens. 2000 ; 18: 1025-1031
22. Province MA, Boerwinkle E, Chakravarti A, et al. Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program. JHypertens. 2000 ; 18: 867-876
23. Kishimoto T, Suyama A, Igarashi A, et al. Angiotensinogen gene variation and hypertension in a cohort study in Japanese. J Epidemiol. 2001 ; 11: 115-119
24. Wang JH, Lin CM, Wang LS, et al. Association between molecular variants of the angiotensinogen gene and hypertension in Amis tribes of eastern Taiwan. J Formos Med Assoc. 2002 ; 101: 183-188
25. Wu X, Luke A, Rieder M, et al. An association study of angiotensinogen polymorphisms with serum level and hypertension in an African-American population. J Hypertension. 2003 ; 21: 1847-1852
26. Niu W, Qi Y, Cen W, et al. Genetic polymorphisms of angiotensinogen and essential hypertension in a Tibetan population. Hypertension Res. 2007 ; 30: 1129-1137
27. Ghazali DM, Rehman A, Rahman AR. Candidate gene polymorphisms and their association with hypertension in Malays. Clinica Chimica Acta. 2008 ; 388: 46-50
28. Basak AA, Sipahi T, Ustundag S, et al. Association of angiotensinogen T174M and M235T gene variants with development of hypertension in Turkish subjects of Trakya region. Biotechnology and Biotechnology Equipment. 2008 ; 22: 984-989
29. Yuan J, Tang W, Chun Y, et al. Angiotensinogen T174M and M235T variants and hypertension in the Hani and Yi minority groups of China. Biochem Genet. 2009 ; 47: 344-350
30. Fasola AF, Martz BL, Helmer OM. Plasma renin activity during supine exercise in offspring of hypertensive patients. J Appl Physiol. 1968 ; 25: 410-415
31. Walker WG, Whelton PK, Saito H, et al. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension. 1978 ; 1: 287-291
32. Gould AB, Green D. Kinetics of human renin and human substrate reaction. Cardiovasc Res. 1971 ; 5: 86-89
33. Gardes J, Bouhnik J, Clauser E, et al. Role of angiotensinogen in blood pressure homeostasis. Hypertension. 1982 ; 4: 185-189
34. Menard J, El-Amrani AIK, Savoie F, et al. Angiotensinogen: Attractive and underrated participants in hypertension and inflammation. Hypertension. 1991 ; 18: 705-706
35. Forrester T, McFarlane-Anderson N, Bennet F, et al. Angiotensinogen and blood pressure among blacks: Findings from a community survey in Jamaica. J Hypertens. 1996 ; 14: 315-321
36. Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991 ; 19: 5444
37. Xiao F, Wei H, Song S, et al. Polymorphisms in the promoter region of the angiotensinogen gene are associated with liver cirrhosis in patients with chronic hepatitis B. J GastroenterolHepatol. 2006 ; 21: 1488-1491
38. Sato N, Katsuya T, Nakagawa T, et al. Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. Life Sci. 2000 ; 68: 259-272
39. Procopciuc L, Popescu T, Jebeleanu G, et al. Essential arterial hypertension and polymorphism of angiotensiongen M235T gene. J Cell Mol Med. 2002 ; 6: 245-250
40. Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001 ; 69: 138-147
41. Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann Med. 2002 ; 34: 88-95
42. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003 ; 19: 376-382
43. Moore JH, Gilbert JC, Tsai CT, et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol. 2006 ; 241: 252-261
44. Ishigami T, Umemura S, Tamura K, et al. Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension. 1997 ; 30: 1325-1330
45. Rahmouni K, Correia MLG WG, et al. Obesity-associated hypertension:New insights into mechanisms. Hypertension. 2005 ; 45: 9
46. Narkiewicz K. Obesity and hypertension-the issue is more complex than we thought. Nephrol Dial Transplant. 2006 ; 21: 264-267
47. Yanai K, Nibu Y, Murakami K, et al. A cis-acting DNA located between TATA box and transcription initiation site is critical in response to regulatory sequence in human angiotensinogen gene. J Biol Chem. 1996 ; 271: 15981-15986
48. Inoue I, Nakajima T, Williams CS, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 1997 ; 7: 1786-1797
49. Jain S, Tang X, Narayanan CS, et al. Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans. JBiol Chem. 2002 ; 277: 36889-36896
50. Wu SJ, Chiang FT, Jiang JR, et al. The G-217A variant of the angiotensinogen gene affects basal transcription and is associated with hypertension in a Taiwanese population. J Hypertens. 2003 ; 21: 2061-2067
51. Robinson M, Williams SM. Role of two angiotensinogen polymorphisms in blood pressure variation. J Hum Hypertens. 2004 ; 12: 865-869
52. Say YH, Ling KH, Duraisamy G, et al. Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: A case control study. BMC CardiovascDisord. 2005 ; 5: 7
53. Nair KG, Shalia KK, Ashavaid TF, et al. Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. J Clin Lab Anal. 2003 ; 17: 141-146
54. Karthikeyan M, Rose R, Shridevi V, et al. Core promoter variants (A-20C, T-18C and G-6A) of the angiotensinogen (AGT) gene are not significantly associated with hypertension in patients of Tamilnadu, India. Int J Hum Genet. 2009 ; 9: 13-19
55. Tiago AD, Samani NJ, Candy GP, et al. Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation. 2002 ; 106: 1483
56. Chaves FJ, Giner V, Corella D, et al. Body weight changes and the A-6G polymorphism of the angiotensinogen gene. Int J Obes Relat Metab Disord. 2002 ; 26: 1173-1178
57. Bennett CL, Schrader AP, Morris BJ. Cross-sectional analysis of Met235->Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun. 1993 ; 197: 833-839
58. Niu W, Qi Y, Hou S, et al. Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: The Fangshan study. J Hypertens. 2009 ; 27: 1384-1391
59. Hata A, Namikawa C, Sasaki M, et al. Angiotensinogen as a risk factor for hypertension in Japan. J Clin Invest. 1994 ; 93: 1285-1287
60. Iwai N, Ohmichi N, Nakamura Y, et al. Molecular variants of the angiotensinogen as a risk factor for essential hypertension in Japanese populations. Hypertens Res. 1994 ; 17: 117-121
61. Kamitani A, Rakugi H, Higaki J, et al. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens. 1994 ; 8: 521-524
62. Nishiuma S, Kario K, Kayaba K, et al. Effect of the angiotensinogen gene Met235->Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens. 1995 ; 13: 717-722
63. Iwai N, Shimoike H, Ohmichi N, et al. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension. 1995 ; 25: 688-693
64. Chiang FT, Hsu KL, Tseng CD, et al. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens. 1997 ; 15: 607-611
65. Ortlepp JR, Metrikat J, Mevissen V, et al. Relation between angiotensionogen (AGT) M235T gene polymorphism and blood pressure in a large homogeneous study population. J Hum Hypertens. 2003 ; 17: 555-559
66. Jain S, Li Y, Patil S, et al. A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity. J Mol Med. 2005 ; 83: 121-131
67. Wu SJ, Chiang FT, Chen WJ, et al. Three single nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: Single locus genotype vs. haplotype analysis. Physiol Genomics. 2004 ; 17: 79-86
68. Williams SM, Addy JH, Phillips JA, et al. Combination of variants in multiple genes are associated with hypertension. Hypertension. 2000 ; 36: 2-6
69. Tsai CT, Fallin D, Chiang FT, et al. Angiotensinogen gene haplotype and hypertension: Interaction with ACE gene I allele. Hypertension. 2003 ; 41: 9-15
70. Wang WY, Glenn CL, Zhang W, et al. Exclusion of angiotensinogen gene in molecular basis of human hypertension: Sibpair linkage and association analysis in Australian Anglo-Caucasians. Am J Med Genet. 1999 ; 87: 53-60
71. Ishigami T, Tamura K, Fujita T, et al. Angiotensinogen gene polymorphism near transcription start site and blood pressure: Role of a T-to-C transition at intron I. Hypertension. 1999 ; 34: 430-434
72. Zhu X, Chang YPC, Yan D, et al. Association between hypertension and genes in the renin-angiotensin system. Hypertension. 2003 ; 41: 1027-1034
73. Zhu X, Yan D, Cooper RS, et al. Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: Findings from the family blood pressure program. Genome Res. 2003 ; 13: 173-181
74. Nejatizadeh A, Kumar R, Stobdan T, et al. Significance of angiotensinogen gene haplotypes and genotypes combinations in hypertension. J Hypertens. 2008 ; 26: 1094-1101
75. Brand E, Ringel J, Sharma AM. Role of the angiotensinogen gene for essential hypertension. Herz. 2000 ; 25: 15-25
76. Li Y, Jain S, Patil S, et al. A haplotype of angiotensinogen gene that is associated with essential hypertension increases its promoter activity in adipocytes. Vascul Pharmacol. 2006 ; 44: 29-33
77. Kumar A, Li Y, Patil S, et al. A haplotype of the angiotensinogen gene is associated with hypertension in African Americans. Clin Exp Pharmacol Physiol. 2005 ; 32: 495-502